About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study of ResCure™ to Treat COVID-19 Infection | Clinical Trials | Clareo Health

Back to clinical trial search

WITHDRAWNPhase 1NCT04395716

A Study of ResCure™ to Treat COVID-19 Infection

This is a Phase I open-label interventional study which will test the efficacy of ResCure™ in the treatment of patients with COVID-19 infection.

Lead sponsor: ProgenaBiome•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

ProgenaBiome

Collaborators

Rinati Skin, LLC

In this Phase I open-label interventional study we will test the efficacy of ResCure™ in the treatment of patients with COVID-19 infection. Patients being treated will have severe respiratory symptoms that are at or near requiring the patient be placed on a ventilator.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Critically ill patients with SARS from COVID-19 infection on respirators OR
•2. Patients with SARS from COVID-19 infection prior or after being placed on respirator
•3. Male or female patients 18 years of age and older

Exclusion Criteria

•1\. Patients less than 18 years of age

Related studies

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more

RECRUITINGPhase 1

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

NCT05101213 · Adenovirus Infection, BK Virus Infection, and more

RECRUITINGPhase 1/2

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

NCT04565665 · COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, and more

RECRUITINGPhase 2

Sonlicromanol in Post-COVID

NCT07298005 · Post COVID Condition

Long COVID Brain Fog: Cognitive Rehabilitation Trial

NCT06095297 · Long COVID, Brain Fog, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 8, 2021Terms

Trial snapshot

StatusWITHDRAWN

PhasePHASE1

Enrollment—

Start dateJan 2020

Last updatedApr 8, 2021

Condition

COVID Covid-19 Corona Virus Infection Sars-CoV2 Coronavirus-19+1 more

Locations shown

ProgenaBiome

Ventura, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 8, 2021Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions